Class: Differentiation (176)
Patent Number: 5994518
This patent covers ways of generating a molecule that has granulocyte colony stimulating activity. It may be that this molecule is similar to G-CSF which is currently sold as "Neupogen" by the company Amgen.
Inventors: Kuga, Tetsuro (Yamaguchi, JP); Miyaji, Hiromasa (Tokyo, JP); Sato, Moriyuki (Tokyo, JP); Okabe, Masami (Shizuoka, JP); Morimoto, Makoto (Shizuoka, JP); Itoh, Seiga (Kanagawa, JP); Yamasaki, Motoo (Tokyo, JP); Yokoo, Yoshiharu (Kanagawa, JP); Yamaguchi, Ka
Assignee: Kyowa Hakko Co., Ltd (JP)
Date of First Priority Issue: Tuesday December 22nd, 1987
Patent Number: 5032507
This patent covers the discover that follicle stimulating hormone releasing protein (FRP) can potentiate the activity of erythropoitin in terms of induce erythropoiesis. The patent covers this concept from three perspectives in its three independent claims. The first perspective is "a method for determining the erythrodifferentiation-potentiating capacity of hematopoietic stem...
Inventors: Yu, John (San Diego, CA); Yu, Alice L. (San Diego, CA); Vaughan, Joan (San Diego, CA); Rivier, Jean E. F. (La Jolla, CA); Vale, Jr., Wylie W. (La Jolla, CA)
Assignee: The Salk Institute for Biological Studies (San Diego, CA)
The Regents of the University of California (Berkeley, CA)
Scripps Clinic and Research Foundation (La Jolla, CA)
Date of First Priority Issue: Sunday December 13th, 1987
Patent Number: 5847078
Disclosed is a novel peptide that is useful for terminally differentiating leukemic cells. This peptide could be generally used for luekemia therapy, but should also be considered in combination with some other differentiation inducing agents such as retinoic acid.
Inventors: Eto, Yuzuru (Yokohama-shi, Kanagawa-ken, JP); Tsuji, Tomoko (Kawasaki-shi, Kanagawa-ken, JP); Takano, Satoshi (Yokohama-shi, Kanagawa-ken, JP); Takezawa, Misako (Yokohama-shi, Kangawa-ken, JP); Yokogawa, Yasunori (Yamato-shi, Kanagawa-ken, JP); Shibai, Hi
Assignee: None stated
Date of First Priority Issue: Wednesday July 2nd, 1986
Patent Number: 6004548
This patent covers hematopoietic stem cell stimulatory peptides and proteins that are analogs of pluripotent G-CSF. These compounds are useful for stimulation of hematopoiesis after ablation with radiotherapy or chemotherapy.
Inventor: Souza, Lawrence M. (Thousand Oaks, CA)
Assignee: Amgen, Inc. (Thousand Oaks, CA)
Date of First Priority Issue: Friday August 23rd, 1985
Patent Number: 5529982
TGF-beta is a cytokine with numerous anti-inflammatory functions. The importance of TGF-beta at controlling inflammation is seen not only in its ability to prevent autoimmunity in several animal models, but also by the fact that tumor cells secrete large quantities of it in order to escape immune-mediated killing.
This patent teaches...
Inventors: Carlino, Joseph (San Leandro, CA); Singh, Naina (Santa Clara, CA); Ellingsworth, Larry (San Jose, CA)
Assignee: Celtrix Pharmaceuticals, Inc. (Santa Clara, CA)
Date of First Priority Issue: Tuesday August 6th, 1985
Patent Number: 4342828
This patent teaches how to make a hematopoietic-stimulatory substance through taking out blood, extracting monocytes and macrophages, culturing them with a glycoprotein from urine, and collecting/concentrating the resulting composition, which is useful for stimulating the proliferation and differentiation of human granulopoietic stem cells. This may be an interesting way to generate growth...
Inventors: Takaku, Fumimaro (Utsunomiya, JP); Ogasa, Katsuhiro (Yokohama, JP); Kuboyama, Morio (Tokyo, JP); Yanai, Nobuya (Tokyo, JP); Yamada, Muneo (Kodaira, JP); Watanabe, Yoshiteru (Tokyo, JP)
Assignee: Morinaga Milk Industry Co., Ltd. (Tokyo, JP)
The Green Cross Corp. (Osaka, JP)
Date of First Priority Issue: Friday July 20th, 1979